AI has a PR problem
The industry that promised to change everything can't seem to change anyone's mind.
The industry that promised to change everything can't seem to change anyone's mind.
Anthropic says its new Claude Mythos model is dangerous enough that the company isn’t selling it.
The chatbot will now direct users to crisis hotlines and avoid “confirming false beliefs.”
OpenAI, Anthropic, and Google join forces against Chinese AI distillation attacks.
A New Yorker investigation on OpenAI reveals new details around how is safety commitments have eroded over the years.
Eli Lilly's $2.75 billion deal with AI drug startup Insilico Medicine is mostly contingent on milestones, since no AI-discovered drug has cleared FDA approval yet.
A federal judge temporarily blocked the Pentagon's blacklisting of Anthropic.
Tech Brew breaks down the biggest tech news, emerging innovations, workplace tools, and cultural trends so you can understand what's new and why it matters.
By subscribing, you accept our Terms & Privacy Policy.